Artificial intelligence (AI) is being used in all areas of clinical trials, from patient recruitment to data analysis, including protocol design.
As a result, ensuring that models are properly trained with reliable and detailed data is vital, especially in protocol design.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
On this week’s edition of the GlobalData Healthcare podcast, editor Abigail Beaney speaks with Gen Li, founder and CEO of Phesi, about the importance of training AI models properly for protocol design and what companies can do if they have issues with their models.
You can listen to this week’s edition of the podcast below:
You can listen to other episodes of the GlobalData Healthcare podcast, which covers clinical trials, pharmaceuticals and medical devices here.
